Investigation of topical amniotic membrane suspension and ReGeneraTing Agent on early corneal stromal healing in rats

• Published in: Veterinary and animal science 2024-06, Vol.24, p.100344-100344, Article 100344
• Main Authors: Lee, Hao, Huang, Wei-Hsiang, Sun, Yi-Chen, Lin, Chung-Tien
• Format: Article
• Language: English
• Subjects: Amniotic membrane suspension; Corneal healing; Corneal ulcer; Optical coherence tomography; ReGeneraTing Agent
• ISSN: 2451-943X; 2451-943X
• DOI: 10.1016/j.vas.2024.100344

•Amniotic Membrane Suspension (AMS) and ReGeneraTing Agent (RGTA) have been shown to enhance the early stages of corneal stromal healing.•The enhancement in corneal wound healing was evident from the increased corneal stromal thickness as observed under optical coherence tomography (OCT) examination.•Further research is necessary to investigate the long-term effects and mechanism of using topical AMS and RGTA on treating deep corneal ulcer in clinical practice. Innovative topical bioregenerative materials promoting corneal stromal healing provide valuable alternatives for treating patients with deep corneal ulcers, and particularly beneficial for those with a higher anaesthetic risk. This study aimed to investigate the effects of topical amniotic membrane suspension (AMS) and ReGeneraTing Agent (RGTA) on surgically induced deep stromal ulcers in rats. Eighteen Sprague-Dawley rats were divided into 3 treatment groups: control group (topical normal saline, TID); AMS group (topical AMS, TID); RGTA group (topical RGTA, Q2D). Corneal microsurgery was used to create deep stromal ulcer. Evaluations were performed by corneal opacity grading, spectral domain optical coherence tomography (SD-OCT), histopathology, and immunohistochemistry. One-way ANOVA and Dunnett's test were used for statistical analysis. By the seventh day of treatment, both the AMS and RGTA groups showed significantly greater thickness in corneal stroma (both p-value < 0.05) than the control group. Additionally, the RGTA group exhibited a significantly higher degree of myofibroblast infiltration in the stroma and a greater level of corneal opacity (p < 0.05). No significant differences in the count of inflammatory cells were noted. In conclusion, both AMS and RGTA have demonstrated effectiveness in promoting the early stages of stromal wound healing and wound defect recovery in our research. Both AMS and RGTA have good potential for treating deep corneal ulcers in small animals practice. Further research is necessary to investigate the long-term effects and mechanism of using topical AMS and RGTA on treating deep corneal ulcer in clinical practice. [Display omitted]